Media News

ÉPERNAY, France, Oct. 19, 2021 /PRNewswire/ -- Moët Hennessy, world leader of high-quality wine and spirits, inaugurates its new Robert-Jean de Vogüé Research Center dedicated to advancing knowledge and evolving practices. Today, climate change and biodiversity loss for more environmentally friendly products have highlighted the limits of the current viticultural model and...

FUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services in China, today announced that its indirectly wholly owned Chinese subsidiary, E-Home Household Service Technology Co., Ltd. ("E-Home WFOE"), has exercised the options to acquire 100% equity interests of each of Fuzhou Bangchang Technology Co....

DAEJEON, South Korea, Oct. 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the patent for PMC-309, one of the Company's first immuno-oncology assets, has been granted by IP Australia, the Australian government agency that administers intellectual property rights. ...

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Oct. 19, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in phase II trial for the treatment of thyroid eye disease (TED). This clinical study aims...

SYDNEY, Oct. 19, 2021 /PRNewswire/ -- The iQ Group Global Ltd (NSX.IQG), on behalf of its subsidiary, Life Science Biosensor Diagnostics Pty Ltd (LSBD), is pleased to announce that one of its licensees, GBS Inc (Nasdaq: GBS); a life sciences company operating in the Asia Pacific region, under license from LSBD, to commercialize its non-invasive, real-time Glucose Salivary...

SHANGHAI, Oct. 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Microtech Medical (SEHK:2235), a leading Chinese diabetes management medical device maker, today listed on the main board of the Hong Kong Stock Exchange. The issue price is HK$ 30.5 per share. The stock opened at HK$ 31 per share, representing a market cap of HK$ 13.1 billion. Qiming...

BEIJING, Oct. 19, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval from the NMPA for its SHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189, which is the company's 9th innovative drug candidate entering clinical development. This China-based Phase Ia/Ib open, single-arm, multicenter study aims...

LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453, by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a Boston-based non-profit accelerating antibacterial research. This extended financing will support the ongoing development of a...

HONG KONG, Oct. 19, 2021 /PRNewswire/ -- Prenetics (the "Company"), a global leader in genomic and diagnostic testing, announced today it has been appointed as the official RT-PCR COVID-19 testing partner for the Standard Chartered Hong Kong Marathon 2021, which is set to take place on October 24. The appointment marks the continued efforts by Prenetics to bring healthcare closer...

Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit SALT LAKE CITY, Oct. 19, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today...